Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC33127 DEX-M-74
N-Acetylmannosamine, also known as ManNAc, DEX M-74, N-acetyl-D-mannosamine, is a drug potentially for the treatment of hereditary inclusion body myopathy
More description
DC33126 P-1075
P-1075, also known as PNU-83757 and U-83757, is a K-ATP channel agonist potentially for the treatment of erectile dysfunction, alopecia and arrhythmia.
More description
DC33125 NSC-48006
FdCyd is a DNA methyltransferase (DNMT) inhibitor potentially for the treatment of solid tumours.
More description
DC33123 SDG
Secoisolarisiresinol diglucoside (SDG) is potentially for the treatment of oxidative stress.
More description
DC33122 SR-97193
Ferroquine is a hemozoin inhibitor potentially for the treatment of malaria.
More description
DC33121 (+/-)-Equol
Equol is a drug is potentially for the treatment of acute thyroid disease and inhibits proliferation of human gastric carcinoma cells. Equol (racemic) is a mixture of S-equol and R-equol.
More description
DC33120 60-P-001
Celgosivir is an α-glucosidase inhibitor potentially for the treatment of dengue fever.
More description
DC33119 Sodium taurocholate
Sodium taurocholate is a GPBAR1 protein agonist potentially for the treatment of type 2 diabetes and obesity in rats.
More description
DC33118 LU-28-179
Siramesine Fumarate is a sigma receptor agonist potentially for the treatment of generalized anxiety disorder
More description
DC33117 NGX-267
NGX-267 is a muscarinic M1 agonist potentially for the treatment of Xerostomia, Alzheimer's disease and cognitive
More description
DC33116 MC-1
Pyridoxyl phosphate is a purinergic P2 receptor antagonist potentially for the treatment of tardive dyskinesia
More description
DC33115 ZD-0947
ZD-0947, also known as AZD-0947, is a K(ATP) channel activator potentially for the treatment of overactive bladder (OAB).
More description
DC33114 NSC-76239
Oxipurinol is a xanthine oxidase inhibitor potentially for the treatment of heart failure and gout.
More description
DC33112 GW-842166X
GW 842166X is a cannabinoid receptor 2 (CB2) agonist potentially for the treatment of inflammatory pain.
More description
DC33110 EM-574
Idremcinal is a motilin receptor agonist potentially for the treatment of gastritis
More description
DC33109 AIM-102
AIM-102 is nonsteroidal, immune modulating, anti-inflammatory drug potentially for the treatment of allergic asthma
More description
DC33102 SR-33805
SR-33805 is a calcium channel antagonist potentially for the treatment of atherosclerosis and heart failure. SR-33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes. A SR33805-induced sensitization of myofilament activation was found to be associated with a slight increase in myosin light chain-2 phosphorylation and a more significant decrease on troponin I (TnI) phosphorylation. Decreased TnI phosphorylation was related to inhibition of protein kinase A activity by SR-33805.
More description
DC33101 Bepafant
Bepafant, also known as WEB-2170 and STY-2108, is a platelet activating factor (PAF) antagonist potentially for the treatment of asthma. Bepafant triggered apoptosis in NB4, KG1, and NB4-MR4 cells where PTEN was expressed, but not in THP1 and U937 cells where PTEN was absent. Bepafant may produce significant anti-inflammatory effects.
More description
DC33100 Indole-3-propionic acid
Indole-3-propionic acid, also known as IPA and SHP-622, is a beta-amyloid protein neurotoxicity inhibitor potentially for the treatment of Friedreich's ataxia. The administration of IPA significantly decreased the level of 4-hydroxy-2-nonenal, a marker of lipid peroxidation, in ischemic hippocampal homogenates compared with that in the vehicle-treated ischemic groups at various times after ischemia/reperfusion. In addition, immunostaining for 8-hydroxy-2'-deoxyguanosine showed DNA damage in pyramidal neurons in the ischemic CA1 was significantly lower in the IPA-treated ischemic groups than in the vehicle-treated ischemic groups. IPA may be used as a pharmacological agent to protect against iron-induced oxidative damage to membranes and, potentially, against carcinogenesis.
More description
DC33099 Histapyrrodine hydrochloride
Histapyrrodine hydrochloride is a bioactive chemical.
More description
DC33098 Lupulon
Lupulon, also known as Lupulone, is a beta-acid that has been found in the hop plant, H. lupulus, and has diverse biological activities, including antibacterial, antioxidant, and anticarcinogenic properties. Lupulone is active against B. subtilis and S. aureus as well as T. b. brucei and L. m. mexicana. It scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals and reduces proliferation, migration, and capillary tube formation in human umbilical vein endothelial cells (HUVECs). Lupulone also activates the extrinsic apoptotic death pathway in SW480 and SW620 colon cancer cells.
More description
DC33097 Spongouridine
Spongouridine is a deamination metabolite of Cytarabine (GLXC-07791).
More description
DC33096 Undecylprodigiosin
Undecylprodigiosin is a classical cytotoxic immunosuppressant, suppressing immune functions and inhibiting DNA synthesis.
More description
DC33095 CAY 10404
CAY10404 is one of the most selective inhibitors of COX-2 over COX-1.
More description
DC33093 ENMD-1068 HBr
ENMD-1068 HBr is a novel antagonist of Proteinase-Activated Receptor 2 (PAR-2).
More description
DC33092 1,3-Dicaffeoylquinic acid
1,3-Dicaffeoylquinic acid is an inhibitor of taste receptors.
More description
DC33091 IWP12
IWP-12 is a potent inhibitor of Porcupine (PORCN), a membrane-bound O-acyltransferase (MBOAT).
More description
DC33089 gammaDGG
gamma-DGG is a broad spectrum glutamate receptor antagonist.
More description
DC33088 Etilevodopa HCl
Etilevodopa HCl is a prodrug of levodopa with greater gastric solubility and significant brain penetration.
More description
DC33087 MitoB
MitoB is a novel exomarker of mitochondrial hydrogen peroxide.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X